Global Health's Q1 FY 2026-27 Quarterly Results

Result Summary

• Global Health Ltd reported a 10.9% quarter-on-quarter (QoQ) increase in its consolidated revenues for the quarter-ended Jun (Q1 FY 2026-27). On a year-on-year (YoY) basis, it witnessed a growth of 26.2%.
• Its expenses for the quarter were up by 10.4% QoQ and 29.0% YoY.
• The net profit increased 11.0% QoQ and decreased 1.1% YoY.
• The earnings per share (EPS) of Global Health Ltd stood at 5.9 during Q1 FY 2026-27.

Financial Statments for Q1 FY 2026-27

Data Source: BSE, Company announcements The securities quoted are exemplary and are not recommendatory. Past performance is not indicative of future results

Company Overview

Global Health Ltd is a company engaged in the healthcare sector. The company primarily focuses on providing health-related services and products. As a healthcare provider, Global Health Ltd may offer a range of services, including hospital services, diagnostics, and possibly pharmaceutical products, aligning with typical operations within the healthcare industry. However, specific details regarding recent major developments or any strategic initiatives undertaken by the company are not available in the present data. This analysis will focus on the financial performance data provided, without delving into unspecified aspects of the company's operations or strategic direction.

Revenue

In the first quarter of the fiscal year 2027 (Q1FY27), Global Health Ltd reported a total income of ₹1326.22 crores. This represents a quarter-over-quarter (QoQ) increase of 10.9% compared to the previous quarter (Q4FY26), where the total income was ₹1195.79 crores. Additionally, there is a year-over-year (YoY) increase of 26.2%, as the total income in the first quarter of the fiscal year 2026 (Q1FY26) was ₹1051.29 crores. The observed growth in revenue indicates a strong performance in terms of income generation over both the preceding quarter and the corresponding quarter of the previous year.

Profitability

For Q1FY27, Global Health Ltd achieved a profit before tax (PBT) of ₹213.26 crores, marking a 13.9% increase QoQ from ₹187.28 crores in Q4FY26. The YoY growth in PBT is 2.5%, as the figure for Q1FY26 was ₹208.14 crores. After accounting for taxes amounting to ₹56.01 crores in Q1FY27, the profit after tax (PAT) stood at ₹157.25 crores. This reflects an 11.0% QoQ increase over the PAT of ₹141.65 crores in Q4FY26. However, there is a slight YoY decline of 1.1% from the ₹158.98 crores reported in Q1FY26. Earnings per share (EPS) for the same period were ₹5.90, which is a 10.3% increase QoQ from ₹5.35, but a marginal decrease of 0.2% YoY from ₹5.91.

Operating Metrics

Total expenses for Q1FY27 were noted at ₹1112.96 crores, witnessing a 10.4% increase QoQ from ₹1008.51 crores in Q4FY26. When compared to Q1FY26, where expenses were ₹862.74 crores, the YoY increase is significant at 29.0%. The tax expense for Q1FY27 was ₹56.01 crores, which has increased by 22.7% QoQ from ₹45.63 crores, and by 13.9% YoY from ₹49.16 crores. The expense growth rate is slightly lower than the income growth rate QoQ, but higher YoY, impacting the overall profitability margins. The analysis of these metrics provides a comprehensive view of Global Health Ltd’s cost structure and its effect on financial performance over the given periods.